Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Korea Beefs Up Infrastructure To Lead Asia In Early-Stage Clinical Trials

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea is drawing more Phase I and Phase II clinical trials from its former foothold in Phase III and post-approval trials, Korea National Enterprise for Clinical Trials reported
Advertisement

Related Content

Korea's Hanwha Chemical Leads With Enbrel Biosimilar - BIO Korea
Korea's Hanwha Chemical Leads With Enbrel Biosimilar - BIO Korea
Seoul National University Hospital Partners With Quintiles On Clinical Trials
More Talks Needed With China and Japan For Cooperation In Sharing Clinical Data - Korea FDA Official
Forget China And India, Clinical Trial Opportunities In Malaysia and South Korea
As Korea Steps Up Drive To Attract Global Clinical Trials, American CRO Opens Outpost In Seoul
MNCs Can Access Asian Markets Faster With Bridging Studies – Parexel Exec
MNCs Can Access Asian Markets Faster With Bridging Studies – Parexel Exec
South Korean Govt Seeks To Allow Foreigners To Run Hospitals In Move To Strengthen Health Care Industry
Multinationals Step Up Clinical Trials In South Korea
Advertisement
UsernamePublicRestriction

Register

SC070773

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel